Stark, K. & Massberg, S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol. 18, 666–682 (2021).
Article PubMed PubMed Central Google Scholar
Esmon, C. T. Molecular circuits in thrombosis and inflammation. Thromb. Haemost. 109, 416–420 (2013).
Article CAS PubMed Google Scholar
Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34–45 (2012).
Khorana, A. A. et al. Cancer-associated venous thromboembolism. Nat. Rev. Dis. Prim. 8, 1–18 (2022).
Mackman, N. et al. Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses. Arterioscler. Thromb. Vasc. Biol. 40, 2033–2044 (2020).
Article CAS PubMed PubMed Central Google Scholar
Rittirsch, D., Flierl, M. A. & Ward, P. A. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776–787 (2008).
Article CAS PubMed PubMed Central Google Scholar
Emmi, G. et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb. J. 13, 15 (2015).
Article PubMed PubMed Central Google Scholar
Sherer, Y. & Shoenfeld, Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat. Clin. Pract. Rheumatol. 2, 99–106 (2006).
Article CAS PubMed Google Scholar
Phillip R., Luqmani, R. Mortality in systemic vasculitis: a systematic review. Clin. Exp. Rheumatol. 26, S94–104 (2008).
Della Rossa, A., Tavoni, A. & Bombardieri, S. Hyperviscosity syndrome in cryoglobulinemia: clinical aspects and therapeutic considerations. Semin. Thromb. Hemost. 29, 473–477 (2003).
Kuramochi, Y. et al. Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatrics Int. 42, 470–475 (2000).
Du, L. et al. Multisystemic manifestations of IgA vasculitis. Clin. Rheumatol. 40, 43–52 (2021).
Article CAS PubMed Google Scholar
Kitching, A. R. et al. ANCA-associated vasculitis. Nat. Rev. Dis. Prim. 6, 71 (2020).
Rathmann, J. et al. Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study. RMD Open 9, e002949 (2023).
Article PubMed PubMed Central Google Scholar
Hellmich, B. et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann. Rheum. Dis. 83, 30–47 (2024).
Moiseev, S. et al. Traditional and disease-specific risk factors for cardiovascular events in antineutrophil cytoplasmic antibody-associated vasculitis: a multinational retrospective study. J. Rheumatol. 50, 1145–1151 (2023).
Mohammad, A. J. et al. Rate of comorbidities in giant cell arteritis: a population-based study. J. Rheumatol. 44, 84–90 (2017).
Kronbichler, A. et al. Comorbidities in ANCA-associated vasculitis. Rheumatology 59 (Suppl. 3), iii79–iii83 (2020).
Article CAS PubMed PubMed Central Google Scholar
Sánchez Álamo, B. et al. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol. Dial. Transplant. 38, 1655–1665 (2023).
Tan, J. A. et al. Mortality in ANCA-associated vasculitis: a meta-analysis of observational studies. Ann. Rheum. Dis. 76, 1566–1574 (2017).
Flossmann, O. et al. Long-term patient survival in ANCA-associated vasculitis. Ann. Rheum. Dis. 70, 488–494 (2011).
Bettiol, A. et al. Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome). Eur. Respir. J. 57, 2004158 (2021).
Article CAS PubMed Google Scholar
Allenbach, Y. et al. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann. Rheum. Dis. 68, 564–567 (2009).
Article CAS PubMed Google Scholar
Clifford, A. H. & Cohen Tervaert, J. W. Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis. Atherosclerosis 325, 8–15 (2021).
Article CAS PubMed Google Scholar
Go, A. S. Cardiovascular disease consequences of CKD. Semin. Nephrol. 36, 293–304 (2016).
Moiseev, S. et al. End-stage renal disease in ANCA-associated vasculitis. Nephrol. Dial. Transplant. 32, 248–253 (2017).
Liapi, M. et al. Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study. Rheumatology 60, 4616–4623 (2021).
Article CAS PubMed Google Scholar
Tabakovic, D. et al. High risk of stroke in ANCA-associated vasculitis-a population-based study. Rheumatology 62, 2806–2812 (2023).
Armbruster, A. L. et al. The role of inflammation in the pathogenesis and treatment of arrhythmias. Pharmacotherapy 42, 250–262 (2022).
Article CAS PubMed Google Scholar
Vegting, Y. et al. Traditional and disease-related cardiovascular risk factors in ANCA-associated vasculitis: a prospective, two-centre cohort study. Joint Bone Spine 90, 105540 (2023).
Moiseev, S. et al. Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study. Rheumatology 60, 4654–4661 (2021).
Article CAS PubMed Google Scholar
Busch, M. H. et al. The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis. Blood Adv. 8, 1295–1304 (2024).
Article CAS PubMed PubMed Central Google Scholar
Go, E. et al. Von Willebrand factor antigen as a marker of disease activity in childhood-onset antineutrophil cytoplasmic antibody–associated vasculitis. Rheumatology 63 (SI2), SI228–SI232 (2024).
van Zaane, B. et al. Systematic review on the effect of glucocorticoid use on procoagulant, anti‐coagulant and fibrinolytic factors. J. Thromb. Haemost. 8, 2483–2493 (2010).
Sartorelli, S. et al. Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss). Rheumatology 61, 1175–1184 (2022).
Comments (0)